EDEM2 Antikörper

Produktnummer ABIN7113869

Produktdetails anti-EDEM2 Antikörper

Target: EDEM2 (ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser EDEM2 Antikörper ist unkonjugiert

Applikation: ELISA, Western Blotting (WB)

Aufreinigung: Immunogen affinity purified

Reinheit: ≥95 % as determined by SDS-PAGE

Immunogen: ER degradation enhancer, mannosidase alpha-like 2

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB: 1:500-1:2000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: -20°C for 12 months (Avoid repeated freeze / thaw cycles.)

Haltbarkeit: 12 months

Details zu EDEM2

Target: EDEM2 (ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2))

Andere Bezeichnung: EDEM2 (EDEM2 Produkte)

Synonyme: C20orf31 antikoerper, C20orf49 antikoerper, bA4204.1 antikoerper, 9530090G24Rik antikoerper, AI327354 antikoerper, RGD1303074 antikoerper, MGC88910 antikoerper, DKFZp459A0314 antikoerper, ER degradation enhancing alpha-mannosidase like protein 2 antikoerper, ER degradation enhancer, mannosidase alpha-like 2 antikoerper, EDEM2 antikoerper, Edem2 antikoerper, edem2 antikoerper

Hintergrund: Synonyms:C20orf31, C20orf49 Background:Initiates the endoplasmic reticulum-associated degradation(ERAD) that targets misfolded glycoproteins for degradation in an N-glycan-dependent manner. Catalyzes the first mannose trimming step, from Man9GlcNAc2 to Man8GlcNAc2(PubMed:25092655). Extracts misfolded glycoproteins, but not glycoproteins undergoing productive folding, from the calnexin cycle.

Molekulargewicht: 60-65 kDa

Gen-ID: 55741

UniProt: Q9BV94